|
Re: Management change at Resverlogix
|
2
|
Resverlogix Corp.
|
Jul 06, 2021 08:06AM
|
|
Re: LINK for the AGM
|
9
|
Resverlogix Corp.
|
Jun 22, 2022 03:30AM
|
|
Re: Leave early!
|
2
|
Resverlogix Corp.
|
Sep 30, 2019 12:28AM
|
|
Re: Is my memory off again? When did the FDA 'sign off' on BETonMACE
|
3
|
Resverlogix Corp.
|
Oct 31, 2019 05:22AM
|
|
Re: Interesting read on the backlash to FDA's approval of aducanumab
|
3
|
Resverlogix Corp.
|
Jun 13, 2021 01:54AM
|
|
Re: Interesting observation today
|
5
|
Resverlogix Corp.
|
Oct 08, 2018 11:52PM
|
|
Re: Interesting comment from DM
|
10
|
Resverlogix Corp.
|
Sep 30, 2019 04:09PM
|
|
Re: Interesting comment from DM
|
2
|
Resverlogix Corp.
|
Sep 30, 2019 12:03PM
|
|
Re: In Brief Published: 14 May 2021 CARDIOVASCULAR RISK Apabetalone in chronic kidney disease
|
4
|
Resverlogix Corp.
|
May 21, 2021 02:01AM
|
|
Re: In Brief Published: 14 May 2021 CARDIOVASCULAR RISK Apabetalone in chronic kidney disease
|
4
|
Resverlogix Corp.
|
May 21, 2021 02:08AM
|
|
Re: I'm as anxious as anyone for this train to get moving....thoughts on stonegate
|
6
|
Resverlogix Corp.
|
Nov 06, 2015 06:13PM
|
|
Re: How common is this infectious pathway, or whatever the correct term is?
|
5
|
Resverlogix Corp.
|
Jan 04, 2021 11:48AM
|
|
Re: Here is the example of the danger of the COVID trial to RVX...
|
2
|
Resverlogix Corp.
|
Nov 12, 2021 11:49AM
|
|
Re: Health Canada Issues Resverlogix Authorization to Begin Immediate Clinical Studies of Apabetalone for COVID-19
|
4
|
Resverlogix Corp.
|
Apr 12, 2021 10:40PM
|
|
Re: Health Canada Issues Resverlogix Authorization to Begin Immediate Clinical Studies of Apabetalone for COVID-19
|
4
|
Resverlogix Corp.
|
Apr 12, 2021 12:37PM
|
|
Re: Health Canada Issues Resverlogix Authorization to Begin Immediate Clinical Studies of Apabetalone for COVID-19
|
6
|
Resverlogix Corp.
|
Apr 12, 2021 04:20PM
|
|
Re: Health Canada Issues Resverlogix Authorization to Begin Immediate Clinical Studies of Apabetalone for COVID-19
|
4
|
Resverlogix Corp.
|
Apr 12, 2021 05:15PM
|
|
Re: Health Canada Issues Resverlogix Authorization to Begin Immediate Clinical Studies of Apabetalone for COVID-19
|
4
|
Resverlogix Corp.
|
Apr 12, 2021 05:27PM
|
|
Re: Great Presetation today - Transcript
|
5
|
Zenith Epigenetics
|
Oct 25, 2017 11:01PM
|
|
Re: Great Discussion
|
2
|
Resverlogix Corp.
|
Oct 18, 2017 06:19PM
|
